We hereby, present the first case of Acute generalized exanthematous pustulosis (AGEP) following treatment with remdesivir in a patient with COVID-19 without hydroxychloroquine use which serves as a reminder for considering remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.

Although the presence of morphea following COVID-19 has been rarely reported, development of its generalized form following COVID-19 vaccination has not been reported yet. Here, we reported the first case of generalized morphea following COVID-19 vaccination and another similar case following SARS-Cov-2 infection. Other etiologic factors were also dealt with

The rare disseminated form of Herpes Zoster occurred mainly in immunocompromised patients. We hereby, present the first case of atypical disseminated herpes zoster in a 54-year old woman admitted with serious COVID. This case serves as a reminder for considering atypical presentations of cutaneous disorders in immunocompromised patients.